C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2004
11/17/2004	EP0931062B1 Conjugates and specific immunoassays for the methadone metabolite 2-ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine
11/17/2004	EP0765477A4 Resins for solid state synthesis
11/17/2004	CN1547575A Novel phenylalkyl diamine and amide analogs
11/17/2004	CN1547561A Method for the production of a purified melt of at least one monomer
11/17/2004	CN1546446A Fluorene derivatives and their application
11/17/2004	CN1176076C Bis(dialkylmaleimide) derivatives and polyetherimide for optical communications
11/17/2004	CN1176075C Pyrrole derivatives preparation method
11/17/2004	CN1176074C Multi-substituted beta-monofluoropyrrole compounds and preparing process thereof
11/16/2004	US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004	US6818644 Fluorene-9-carboxylic amides; inhibitors of microsomal triglyseride-transfer protein (mtp); antilipemic agents; atherosclerosis, diabetes, eating disorders, and pancreatitis
11/16/2004	US6818635 For therapy of bacterial infections and neoplasms,
11/16/2004	US6818622 Selective MMP inhibitors having reduced side-effects
11/16/2004	US6818593 Production of 5-Methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds
11/16/2004	CA2092306C Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
11/11/2004	WO2004096795A2 C-fms kinase inhibitors
11/11/2004	WO2004096764A1 Method of preparing a ring compound having two adjacent chiral centers
11/11/2004	WO2004096761A1 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
11/11/2004	WO2004080376A3 Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer’s disease
11/11/2004	WO2004073598A3 Solid phase synthesis of antitumoral compounds
11/11/2004	WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
11/11/2004	WO2003050085A8 CRYSTALLINE [R-(R,R)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-HEPTANOIC ACID CALCIUM SALT (2:1)
11/11/2004	US20040225133 Process for chemical reaction of amino acids and amides yielding selective conversion products
11/11/2004	US20040225105 Preparing a polyalkenyl derivative of an unsaturated acidic reagent; reacting the unfiltered product with a polyamine having at least one basic nitrogen atom; diluting the product; and subsequently filtering the polyalkenylsuccinimide product
11/11/2004	US20040225026 Imide-linked maleimide and polymaleimide compounds
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040224985 for controlling weight; pyrrolidine or piperidine compounds
11/11/2004	US20040224978 CCR8 inhibitors
11/11/2004	US20040224928 For therapy of bacterial infections and neoplasms,
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/11/2004	US20040224875 Inhibitors of glutaminyl cyclase
11/11/2004	CA2536964A1 C-fms kinase inhibitors
11/11/2004	CA2523585A1 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
11/11/2004	CA2523356A1 Method of preparing a ring compound having two adjacent chiral centers
11/10/2004	EP1475393A1 Improved process for preparing polyalkenylsuccinimides
11/10/2004	EP1474440A2 Coniosulphides and their derivatives, method for their production and use as medicaments
11/10/2004	EP1474419A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
11/10/2004	EP1474389A2 Delta1-pyrrolines
11/10/2004	EP1085009B1 Indan derivatives
11/10/2004	CN1545516A Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
11/10/2004	CN1544418A N-aryl substituted-1H-pyrrole derivative possessing cardiovascular activity
11/10/2004	CN1174958C Purification process of keto acid
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815458 Nervous system disorders
11/09/2004	CA2144344C Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents
11/04/2004	WO2004094412A1 Nk-2 antagonist basic linear compounds and formulations containing them
11/04/2004	WO2004094382A1 Muscarinic agonists
11/04/2004	WO2004094375A2 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
11/04/2004	WO2004080951A3 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
11/04/2004	WO2004067703A3 5ht7 antagonists and inverse agonists
11/04/2004	WO2004042351A3 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/04/2004	WO2004004657A3 Hiv integrase inhibitors
11/04/2004	WO2003087044A3 Novel carboxamide compounds for use in mch receptor related disorders
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	US20040220412 Compositions and kits pertaining to analyte determination
11/04/2004	US20040220411 Oxalic acid derivatives
11/04/2004	US20040220255 Crystalline forms of atorvastatin
11/04/2004	US20040220254 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl) ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
11/04/2004	US20040220238 Pyrrolidine oxadiazole-and thiadiazole derivatives
11/04/2004	US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004	US20040220200 Compositions useful as protein kinase inhibitors
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220191 Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
11/04/2004	US20040220112 administering 2-(N-Methylsulfonamido-2-aminophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide as an anti-pruritic agent; antihyperalgesics; analgesics; central nervous system side effect reduction
11/04/2004	US20040219686 Methods and mixtures pertaining to analyte determination
11/04/2004	US20040219685 Using mass analysis to monitor concentration of analytes in fluids; electrophilic and chromatographic separation
11/04/2004	CA2523200A1 Nk-2 antagonist basic linear compounds and formulations containing them
11/04/2004	CA2522631A1 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
11/04/2004	CA2518324A1 Muscarinic agonists
11/03/2004	EP1472220A1 Crystalline (r-(r,r))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-heptanoic acid calcium salt (2:1)
11/03/2004	EP1472217A2 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
11/03/2004	EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004	EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004	EP1242521B1 Recovery of modifier compounds and polar organic compounds from a poly(arylene sulfide) recycle mixture
11/03/2004	EP1189883B1 Substituted pyrrolidines as cell adhesion inhibitors
11/03/2004	EP1083899A4 Method of enhancing lysosomal alpha-galactosidase a
11/03/2004	CN1543468A Processes for preparing calcium salt forms of statins
11/03/2004	CN1543461A Melanocortin receptor ligands
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1542001A Small molecule inhibitors of rotamase enzyme activity
11/03/2004	CN1173947C 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
11/03/2004	CN1173946C Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/03/2004	CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments
11/02/2004	US6812350 Antidiabetic agents; metabolism diseases; hypotensive agents; cardiovascular disorders
11/02/2004	US6812344 1-(4-Arylpiperazin-1-yl)-ω-[N-(α,ω-dicarboximidoL)]-alkanes useful as uro-selective α1-adrenoceptor blockers
11/02/2004	US6812241 Nitrogen-containing heterocycles having parasiticidal properties
11/02/2004	US6812240 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
11/02/2004	US6812231 Inhibiting activated blood-coagulation factor x
10/2004
10/28/2004	WO2004092164A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
10/28/2004	WO2004092129A1 New process for preparing 4-aminomethyl-3-alkoxyiminopyrrolidine methanesulfonate
10/28/2004	WO2004092128A1 Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile
10/28/2004	WO2004092127A1 Process for the preparation of n-substituted 2-cyanopyrrolidines
10/28/2004	WO2004092126A2 Process and intermediates for the preparation of pyrrolidine carboxylic acids
10/28/2004	WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004	WO2004091867A1 Processing method and processing device
10/28/2004	WO2004091605A1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
10/28/2004	WO2004078732B1 N-aryl heteroaromatic products, compositions containing same and use thereof
10/28/2004	WO2004078103A3 G-lactam derivatives as prostaglandin agonists
10/28/2004	US20040215001 Metal complexes of heterocyclic aromatic compounds

1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 404